Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 41 papers were listed this time. Here's a few in our areas of research interest:
Lung TW, Clarke PM, Hayes AJ, et al. Simulating Lifetime Outcomes Associated with Complications for People with Type 1 Diabetes. Pharmacoeconomics. 2013 Apr 13. [Epub ahead of print] PubMed PMID: 23585309.
Gulliford MC, Charlton J, Bhattarai N, et al. Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care: population-based Cohort study and Markov model. Eur J Health Econ. 2013 Apr 10. [Epub ahead of print] PubMed PMID: 23572044.
van Wier MF, Lakerveld J, Bot SD, et al. Economic evaluation of a lifestyle intervention in primary care to prevent type 2 diabetes mellitus and cardiovascular diseases: a randomized controlled trial. BMC Fam Pract. 2013 Apr 4;14(1):45. [Epub ahead of print] PubMed PMID: 23557482.
Skally M, Hanly P, Sharp L. Cost Effectiveness of Fecal DNA Screening for Colorectal Cancer: A Systematic Review and Quality Appraisal of the Literature. Appl Health Econ Health Policy. 2013 Apr 3. [Epub ahead of print] PubMed PMID: 23549792.
Visconti AJ, Doyle JS, Weir A, et al. Assessing the cost-effectiveness of treating chronic hepatitis C virus in people who inject drugs in Australia. J Gastroenterol Hepatol. 2013 Apr;28(4):707-16. PubMed PMID: 23173753.
Hiligsmann M, Sedrine WB, Reginster JY. Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women. J Bone Miner Res. 2013 Apr;28(4):807-15. PubMed PMID: 23165656.